Ftse Mib
34.339,42
-0,92%
DAX
18.562,52
-0,65%
S&P 500
5.306,04
0,02%
NASDAQ
0,00
0,00%
Bitcoin
67.927,38
-0,53%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Catalyst Biosciences Inc (CBIO) Catalyst Biosciences Inc (CBIO) Notizie

CBIO

Catalyst Biosciences (CBIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CBIO
DataOraFonteTitoloSimboloCompagnia
03/05/202400:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
01/05/202422:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202414:49Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202414:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202414:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
19/04/202422:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
26/03/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
22/03/202401:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
24/01/202423:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
19/01/202422:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
29/11/202322:01Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CBIOCatalyst Biosciences Inc
23/11/202301:06Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
13/11/202323:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CBIOCatalyst Biosciences Inc
30/10/202317:00GlobeNewswire Inc.Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitNASDAQ:CBIOCatalyst Biosciences Inc
30/10/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CBIOCatalyst Biosciences Inc
27/10/202323:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CBIOCatalyst Biosciences Inc
26/10/202323:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CBIOCatalyst Biosciences Inc
24/10/202322:08Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
24/07/202322:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CBIOCatalyst Biosciences Inc
20/07/202314:57Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CBIOCatalyst Biosciences Inc
12/07/202322:30Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CBIOCatalyst Biosciences Inc
26/06/202322:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBIOCatalyst Biosciences Inc
20/06/202323:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBIOCatalyst Biosciences Inc
30/03/202322:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBIOCatalyst Biosciences Inc
28/02/202317:45AllPennyStocks.comBiotech Soars On Asset Purchase AgreementNASDAQ:CBIOCatalyst Biosciences Inc
28/02/202314:00GlobeNewswire Inc.Catalyst Biosciences Provides Corporate UpdateNASDAQ:CBIOCatalyst Biosciences Inc
13/02/202320:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202322:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202312:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBIOCatalyst Biosciences Inc
27/12/202213:00GlobeNewswire Inc.Catalyst Biosciences Completes First Steps in Reverse Merger PlanNASDAQ:CBIOCatalyst Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CBIO

La tua Cronologia

NYSE
AIZP
Assurant
COIN
METROBTC
LSE
0HR2
Cme
EU
CFN
Cofina SGPS
AQSE
VHYD.GB
Vanguard Ftse Allworld H...
BIT
P18DP7
BNP Paribas Issuance
BIT
F38000
Vontobel Financial Produ...
BIT
P1LP83
BNP Paribas Issuance
BIT
1EUZ
Eckert & Ziegler
USOTC
SATOF
Sato (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network